Y.b Urban Renewal - Residential Development Ltd. · TASE:YBRD
Y.b Urban Renewal - Residential Development — Cannassure Therapeutics — Investor Presentation (March 2019)
18 slides from Y.b Urban Renewal - Residential Development's investor presentation, March 2019
Slide 1: Investors Deck | March 2019
Investors Deck | March 2019 TASE: Cannassure Therapeutics Ltd
Slide 2: Forward Looking Statements
22 This presentation has been prepared by the affected from risk factors that characterize Company and should not be considered as the company's operations, as well as from Forward a recommendation or recommendation for developments in the competitive and Looking the purchase or sale of securities a
Slide 3: Our Vision, Our Mission
3 Our Cannassure's vision is to become a leading, world-class, trusted developer and provider of top-quality medical grade cannabis products as well as Vision pharmaceutical cannabinoid medicines, addressing a broad range of unmet medical needs. Our Cannassure will develop and commercialize a wide r
Slide 4: Our Company
4 Our Company Cannassure (TASE symbol: CSURE) is launching a holistic and integrated medical cannabis value chain operation. Activity includes breeding, cultivation, extraction, R&D and distribution of medical cannabis products The company was founded by Solbar Food Technologies (~ 69.5%), a leading
Slide 5: Major Activities So Far
5 Major Activities So Far In the process of extracting and processing, cannabis Initiated preliminary development plan for unique oil for the purpose of developing production procedures pharmaceutical cannabis products in the company's certified lab Granted financial support by the Israel Innovation
Slide 6: Solbar Food Technologies Group
6 Solbar Food Technologies Group The group invested 17.5M ILS in Cannassure Cannassure is based on the know-how and experience of A 60-year-old leading company of high quality botanical extractions Solbar, including the extraction and processing of botanical extracts in a controlled Customers over t
Slide 7: Executive Team
7 Executive Team Major General Ido Nehushtan Nir Peles, CPA, MBA, MA(LAW) Chairman of the Board Founder, BOD Member & VP Business Development Former commander of the Israel Air Force and Head A seasoned entrepreneur with extensive of the IDF Planning Directorate, Mr. Nechushtan brings knowledge in b
Slide 8: Executive Team
8 Executive Team Steven Eitan Adi Neufeld VP Strategy CFO Bringing 30 years of experience in leading and managing With 13 years of experience in various finance international biomed and hi-tech companies from start-up positions, Mr. Neufeld has served three years to market penetration and sales, inc
Slide 9: Medical Cannabis Opportunity and Global Market Trends
9 Major trends in the medical cannabis Medical Cannabis- global market: Opportunity and Global Widespread recognition of the virtues and Market Trends effectiveness of medical cannabis products Significant increase in demand for medical cannabis treatments for dozens of medical indications Global ca
Slide 10: Leading Cannabis Companies
10 Leading Cannabis Companies Trailing 12 months Market Cap Company Symbol Revenues Feb 1st, 2019 Millions US dollars Billions US dollars Canopy Growth WEED.TO $73M $16.8B Tilray TLRY $33M $7.7B Aurora ACB.TO $60M $7.4B GW GWPH $13M $4.5B Cronos Inc CRON $9M $3.7B Aphria APHA $47M $2.4B We do it rig
Slide 11: Cannassure is Establishing a Comprehensive Value Chain
11 Cannassure is Development of unique cannabis strains Creating value for the medical cannabis and Establishing a pharmaceutical industries, using advanced breeding Comprehensive Value Breeding technology Chain, Including All Building an indoor growing facility Cultivation in a controlled environme
Slide 12: Indoor Growing Facility
12 Indoor Growing Facility Indoor cultivation enables quality and consistent products and has significant advantages including: Increase of annual growth Higher efficiency by savings ~ 20 tons potential cycles (approximately 6 in water and grow area cycles compared to 2-3 annual capacity of cycles i
Slide 13: Medical Cannabis Extraction and Processing
13 Medical Cannabis Extraction and Processing 1 Cannassure is in advanced stages of building an IMC - GMP approved extraction facility Current extraction and processing activities in the company's lab: for controlled production of high quality oils, cannabinoids and active pharmaceutical Developing
Slide 14: Hadassah Medical - A Strategic Partnership for Distribution in Israel
14 Hadassah Medical- A Strategic Partnership for Distribution in Israel and Commercial Activity Expansion in International Markets Cannassure has signed an Cannassure is planning agreement with Hadassah to operate throughout Medical for marketing and selling Hadassah Medical's medical cannabis oil w
Slide 15: Innovative Medical Cannabis Products Development
15 Innovative Medical Cannabis Products Development Cannassure intends to develop Cannassure is in the planning A proprietary patent and commercialize pharma-grade phase of developing a new application was filed products, for life threatening product based on a combination by Cannassure's expert dis
Slide 16: Next Steps, Key Milestones 2019
17 Next Steps, Key Milestones 2019 8.2018 6.2019 7.2019 H2/2019 and onwards Extracting Completion of Completion of Ready for production medical extraction and indoor grow facility and sale of IMC - GMP cannabis in processing facility, for breeding new approved medical the analytical in accordance wi
Slide 17: Cannassure's Competitive Advantages Summary
Cannassure's Competitive Advantages Summary 18 Founded on the know-how, experience and expertise of Solbar Group, a leader in the food and agriculture industry and benefits from its infrastructure and financial support Skilled highly experienced management team in international business, bio-tech, n
Slide 18: Thank You
19 Thank You TASE: March 2019 | Ran Amir Ran.amir@cannassure.life www.linkedin.com/company/cannassure © Cannassure Therapeutics Ltd
Cannassure Therapeutics — Investor Presentation (March 2019) on 6ix